Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism

Correa, Pamela LU ; Akerstrom, Goran and Westin, Gunnar (2002) In European Journal of Endocrinology 147(5). p.5-671
Abstract

OBJECTIVE: Primary hyperparathyroidism (pHPT) is characterized by excessive production of parathyroid hormone (PTH) due to parathyroid adenomas while uremic secondary HPT (sHPT) is caused by parathyroid hyperplasia in response to renal failure. Active vitamin D, 1,25-dihydroxyvitamin D(3) (1,25-(OH)(2)D(3)), with the vitamin D receptor (VDR) is involved in regulation of the calcium homeostasis together with PTH. In a feedback loop, 1,25-(OH)(2)D(3) has a direct action on the parathyroid gland to regulate PTH transcription, PTH secretion and cell proliferation. We have previously demonstrated reduced VDR mRNA expression in parathyroid adenomas and hyperplasia of sHPT using a probe detecting all 14 variant VDR transcripts expressed in... (More)

OBJECTIVE: Primary hyperparathyroidism (pHPT) is characterized by excessive production of parathyroid hormone (PTH) due to parathyroid adenomas while uremic secondary HPT (sHPT) is caused by parathyroid hyperplasia in response to renal failure. Active vitamin D, 1,25-dihydroxyvitamin D(3) (1,25-(OH)(2)D(3)), with the vitamin D receptor (VDR) is involved in regulation of the calcium homeostasis together with PTH. In a feedback loop, 1,25-(OH)(2)D(3) has a direct action on the parathyroid gland to regulate PTH transcription, PTH secretion and cell proliferation. We have previously demonstrated reduced VDR mRNA expression in parathyroid adenomas and hyperplasia of sHPT using a probe detecting all 14 variant VDR transcripts expressed in parathyroid cells. Here we have assessed which of the 5'-terminal exon 1a, 1d and 1f variant VDR transcripts are reduced in pathological parathyroid glands.

METHODS: The relative VDR/glyceraldehyde-3-phosphate dehydrogenase mRNA levels for each VDR exon were determined by real-time quantitative RT-PCR in five normal parathyroid glands, seventeen parathyroid adenomas and ten hyperplastic glands of sHPT.

RESULTS: The results demonstrated exclusive underexpression of VDR exon 1f transcripts in parathyroid adenoma, while all measured VDR transcripts were reduced in secondary hyperplasia.

CONCLUSIONS: We suggest that exclusive underexpression of VDR exon 1f transcripts in adenomas of pHPT, which derive from a distal promoter active in tIssues involved in calcium regulation by 1,25-(OH)(2)D(3), may either reflect a defective cell type-specific transcription factor or other physiologically important pathway(s) for tIssue-specific VDR gene expression.

(Less)
Please use this url to cite or link to this publication:
author
; and
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Adenoma/complications, Aged, Exons/genetics, Female, Humans, Hyperparathyroidism/etiology, Hyperplasia, Male, Middle Aged, Parathyroid Diseases/metabolism, Parathyroid Glands/metabolism, Parathyroid Neoplasms/complications, RNA, Messenger/metabolism, Receptors, Calcitriol/genetics, Reference Values
in
European Journal of Endocrinology
volume
147
issue
5
pages
5 - 671
publisher
Society of the European Journal of Endocrinology
external identifiers
  • scopus:0036856369
  • pmid:12444900
ISSN
0804-4643
DOI
10.1530/eje.0.1470671
language
English
LU publication?
no
id
5dd1d71f-5760-443a-8c89-609ddd6b05dc
date added to LUP
2021-11-29 10:45:49
date last changed
2024-01-05 21:21:48
@article{5dd1d71f-5760-443a-8c89-609ddd6b05dc,
  abstract     = {{<p>OBJECTIVE: Primary hyperparathyroidism (pHPT) is characterized by excessive production of parathyroid hormone (PTH) due to parathyroid adenomas while uremic secondary HPT (sHPT) is caused by parathyroid hyperplasia in response to renal failure. Active vitamin D, 1,25-dihydroxyvitamin D(3) (1,25-(OH)(2)D(3)), with the vitamin D receptor (VDR) is involved in regulation of the calcium homeostasis together with PTH. In a feedback loop, 1,25-(OH)(2)D(3) has a direct action on the parathyroid gland to regulate PTH transcription, PTH secretion and cell proliferation. We have previously demonstrated reduced VDR mRNA expression in parathyroid adenomas and hyperplasia of sHPT using a probe detecting all 14 variant VDR transcripts expressed in parathyroid cells. Here we have assessed which of the 5'-terminal exon 1a, 1d and 1f variant VDR transcripts are reduced in pathological parathyroid glands.</p><p>METHODS: The relative VDR/glyceraldehyde-3-phosphate dehydrogenase mRNA levels for each VDR exon were determined by real-time quantitative RT-PCR in five normal parathyroid glands, seventeen parathyroid adenomas and ten hyperplastic glands of sHPT.</p><p>RESULTS: The results demonstrated exclusive underexpression of VDR exon 1f transcripts in parathyroid adenoma, while all measured VDR transcripts were reduced in secondary hyperplasia.</p><p>CONCLUSIONS: We suggest that exclusive underexpression of VDR exon 1f transcripts in adenomas of pHPT, which derive from a distal promoter active in tIssues involved in calcium regulation by 1,25-(OH)(2)D(3), may either reflect a defective cell type-specific transcription factor or other physiologically important pathway(s) for tIssue-specific VDR gene expression.</p>}},
  author       = {{Correa, Pamela and Akerstrom, Goran and Westin, Gunnar}},
  issn         = {{0804-4643}},
  keywords     = {{Adenoma/complications; Aged; Exons/genetics; Female; Humans; Hyperparathyroidism/etiology; Hyperplasia; Male; Middle Aged; Parathyroid Diseases/metabolism; Parathyroid Glands/metabolism; Parathyroid Neoplasms/complications; RNA, Messenger/metabolism; Receptors, Calcitriol/genetics; Reference Values}},
  language     = {{eng}},
  number       = {{5}},
  pages        = {{5--671}},
  publisher    = {{Society of the European Journal of Endocrinology}},
  series       = {{European Journal of Endocrinology}},
  title        = {{Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism}},
  url          = {{http://dx.doi.org/10.1530/eje.0.1470671}},
  doi          = {{10.1530/eje.0.1470671}},
  volume       = {{147}},
  year         = {{2002}},
}